Evidence map›Paper›PMID 37446599›Full record

ReviewMolecules (Basel, Switzerland)2023

Antioxidant and Antidiabetic Properties of Phlorotannins from

Mauro Gisbert, Daniel Franco, Jorge Sineiro, Ramón Moreira

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Marine drugs · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mauro GisbertChemical Engineering Department, Universidade de Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain.ORCID 0000-0001-5923-4651
Daniel FrancoChemical Engineering Department, Universidade de Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-0093-7042
Jorge SineiroChemical Engineering Department, Universidade de Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain.ORCID 0000-0001-6700-4530
Ramón MoreiraChemical Engineering Department, Universidade de Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-6388-0063
Universidade de Santiago de Compostela · ESUniversity College Dublin · IE

Funding

European Regional Development Fund (ERDF) of European Union RTI2018-095919-B-C2
6 · The paper itself

Abstract

Seaweeds have gained considerable attention in recent years due to their potential health benefits and high contents of bioactive compounds. This review focuses on the exploration of seaweed's health-promoting properties, with particular emphasis on phlorotannins, a class of bioactive compounds known for their antioxidant and antidiabetic properties. Various novel and ecofriendly extraction methods, including solid-liquid extraction, ultrasound-assisted extraction, and microwave-assisted extraction are examined for their effectiveness in isolating phlorotannins. The chemical structure and isolation of phlorotannins are discussed, along with methods for their characterization, such as spectrophotometry, nuclear magnetic resonance, Fourier transform infrared spectroscopy, and chromatography. Special attention is given to the antioxidant activity of phlorotannins. The inhibitory capacities of polyphenols, specifically phlorotannins from

Indexed as

AscophyllumSeaweedAntioxidantsHypoglycemic AgentsPolyphenolsVegetablesAntioxidantsHypoglycemic AgentsPolyphenolsantioxidant activitybioactivitydigestive enzymes inhibitionfunctional foodphlorotanninspolyphenolssolid–liquid extractionultrasound-assisted extractionα-amylaseα-glucosidase

Identifiers

PMID37446599
PMCPMC10343254
OpenAlexW4382136526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.